UMN Phrama's Other Investors

UMN Phrama raised a round of funding on , . Investors include Mitsubishi UFJ Capital.

UMN-01, a anti-cancer product for which the company have licensed exclusive worldwide rights, is a small molecule down-regulator of GRP78, a 78 kDa glucose regulated protein that belongs to the HSP70 …

Articles about UMN Phrama's Other Investors: